Methicillin-Resistant Staphylococcus aureus carriage and risk factors for skin infections, Southwestern Alaska, USA.
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are common in southwestern Alaska. Outbreak strains have been shown to carry the genes for Panton-Valentine leukocidin (PVL). To determine if carriage of PVL-positive CA-MRSA increased the risk for subsequent soft tissue infection, we conducted a retrospective cohort study by reviewing the medical records of 316 persons for 3.6 years after their participation in a MRSA nasal colonization survey. Demographic, nasal carriage, and antimicrobial drug use data were analyzed for association with skin infection risk. Skin infections were more likely to develop in MRSA carriers than in methicillin-susceptible S. aureus carriers or noncarriers of S. aureus during the first follow-up year, but not in subsequent years. Repeated skin infections were more common among MRSA carriers. In an area where PVL-containing MRSA is prevalent, skin infection risk was increased among MRSA nasal carriers compared with methicillin-susceptible S. aureus carriers and noncarriers, but risk differential diminished over time.
Stevens
A Michal
AM
Centers for Disease Control and Prevention, Anchorage, Alaska 99508-5932, USA.
Hennessy
Thomas
T
Baggett
Henry C
HC
Bruden
Dana
D
Parks
Debbie
D
Klejka
Joseph
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000413:Alaska / Q000453:epidemiology; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000235:genetics; D002353:Carrier State / Q000453:epidemiology / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005098:Exotoxins / Q000235:genetics; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007956:Leukocidins / Q000235:genetics; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D008875:Middle Aged; D009296:Nasal Cavity / Q000382:microbiology; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D013997:Time Factors
D000890:Anti-Infective Agents; D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin
Scand J Infect Dis. 2002;34(10):763-4
12477329
Clin Infect Dis. 2004 Nov 15;39(10):1446-53
15546080
Ann Emerg Med. 2005 Mar;45(3):311-20
15726056
South Med J. 2005 Jun;98(6):596-602
16004165
J Clin Microbiol. 2004 Sep;42(9):4050-3
15364988
MMWR Morb Mortal Wkly Rep. 2003 Oct 17;52(41):992-6
14561958
Emerg Infect Dis. 2004 Jan;10(1):121-4
15078606
Scand J Infect Dis. 2000;32(6):587-95
11200366
J Hosp Infect. 1995 Sep;31(1):13-24
7499817
Clin Microbiol Rev. 1997 Jul;10(3):505-20
9227864
JAMA. 2001 Sep 12;286(10):1201-5
11559265
Am J Public Health. 2008 Nov;98(11):2072-8
18382002
Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):848-50
16341520
Clin Infect Dis. 1999 Nov;29(5):1231-8
10524968
Ann Intern Med. 1991 Jan 15;114(2):107-12
1984384
J Lab Clin Med. 1999 Jun;133(6):525-34
10360626
West J Med. 2000 Apr;172(4):235-9
10778372
MMWR Morb Mortal Wkly Rep. 2003 Feb 7;52(5):88
12588006
Infect Control Hosp Epidemiol. 2003 Jun;24(6):397-402
12828314
Emerg Infect Dis. 2008 Nov;14(11):1693-9
18976551
Arch Intern Med. 1998 Apr 27;158(8):895-9
9570176
MMWR Morb Mortal Wkly Rep. 2003 Aug 22;52(33):793-5
12931079
Clin Infect Dis. 2004 Oct 1;39(7):971-9
15472848
Clin Infect Dis. 2005 Jul 15;41(2):159-66
15983910
J Infect Dis. 2004 May 1;189(9):1565-73
15116291
Am J Med. 1996 Jan;100(1):24-31
8579083
J Hosp Infect. 2001 Feb;47(2):104-9
11170773
Infect Control. 1984 Jul;5(7):326-31
6376403